Area of research
Infectious Diseases · Physiology
Research interest
Research topics from publications: Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies; Future Prospect of Oral Microbiota Influencing Allergy/Asthma Development; The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies; The Gut Microbiome and Acute Leukemia: Implications for Early Diagnostic and New Therapies. Representative work: Allergic diseases have become a primary public health issue in a moderately prosperous society. Colonization of microorganisms early in life appears to be significant in guiding the regulation of childhood immune system maturation and allergy development. Since the oral cavity is the first position where most foreign antigens meet the immune system, the oral microbiota may play a key role in the development of allergies. However, the study on the effects of oral microorganisms on allergy/asthma is very restricted and should be actively investigated. It requires considerable effort to enrich our knowledge in this area of the relationship between the oral cavity and allergy/asthma. To promote Alopecia areata (AA) accounts for the autoimmune disorder mediated by T cells, whose prognostic outcome cannot be predicted and curative treatment is unavailable at present. The AA pathogenic mechanism remains largely unclear, even though follicular attack has been suggested to result from that attack of immune privilege-losing hair follicles driven by immunity. Recently, gut microbiota is suggested to have an important effect on immunoregulation under autoimmune situations like AA. Fecal microbial transplantation (FMT) may be used to treat AA. Nonetheless, related research remains at the initial stage. To promote the rapid progress of relevant research, the present work aimed to shed more l
The Gut Microbiome and Acute Leukemia: Implications for Early Diagnostic and New Therapies
Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies
Future Prospect of Oral Microbiota Influencing Allergy/Asthma Development
The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies